Teladoc Health, Inc. - TDOC STOCK NEWS

Teladoc Health (NYSE: TDOC) will participate in the Canaccord Genuity 40th Annual Growth Conference on August 13, 2020, at 8:30 a.m. EDT. CEO Jason Gorevic and CFO Mala Murthy will join Zane Burke of Livongo for the event. A live audio webcast and replay will be accessible online. Teladoc Health is a leader in virtual care, offering millions of medical visits globally across 175 countries. It has been recognized for patient satisfaction and KLAS rankings in virtual care platforms, showcasing its growth and commitment to enhancing healthcare access.

Teladoc Health (TDOC) has announced a definitive merger agreement with Livongo (LVGO), creating a global leader in consumer-centered virtual care. The merger, valued at $18.5 billion, combines Teladoc's virtual healthcare services with Livongo's chronic condition management technology. It aims to enhance healthcare access, quality, and outcomes, targeting expected pro forma revenue of approximately $1.3 billion for 2020. The companies plan to achieve revenue synergies of $100 million by the second year post-merger, with potential to reach $500 million by 2025, benefiting shareholders and healthcare consumers alike.

Teladoc Health reported an impressive Q2 2020, with revenues soaring 85% year-over-year to $241 million and total visits up 203% to 2.8 million. For the first half of 2020, revenue grew 63% to $421.8 million. The company’s U.S. paid membership reached 51.5 million, a 92% increase, driven by heightened demand for virtual care during the COVID-19 pandemic. Net loss narrowed to $(25.7 million), with improved EBITDA metrics. For Q3 2020, Teladoc anticipates revenue between $275 million and $285 million and a positive outlook for 2021, forecasting 30-40% revenue growth.

Teladoc Health (TDOC) is set to announce its second-quarter results on July 29, 2020, after the market closes. A conference call will follow at 4:30 p.m. E.T., accessible via phone or live audio webcast. The company is recognized as a leader in virtual care, providing millions of medical visits globally each year. Teladoc is ranked high in customer satisfaction and virtual care platforms, indicating strong market positioning. Investors can expect detailed financial metrics during the upcoming call.

Teladoc Health (NYSE: TDOC) has successfully completed its acquisition of InTouch Health for approximately $150 million in cash and 4.6 million shares of its common stock. This acquisition enhances Teladoc's telehealth solutions, linking providers across various medical environments, and positions the company as a comprehensive virtual care partner. The integration aims to improve care access and health outcomes amid growing demand for telemedicine, especially after the COVID-19 pandemic. Key executives highlight the urgency and readiness of healthcare systems to adopt unified virtual care strategies.

Teladoc Health (NYSE: TDOC) has expanded its telemedicine services to First Nations and Inuit populations in Canada through a partnership with Johnston Group. This initiative, part of the CINUP program, aims to address healthcare access issues for over 350 employers within these communities, where many employees are far from primary care facilities. The expansion is timely, given that nearly 40% of Canada’s Aboriginal population lives in rural areas, and only 8% of Canadian doctors practice there. Improved access to virtual care is expected to reduce absenteeism and healthcare-related productivity issues in the workplace.

Teladoc Health (NYSE: TDOC), a leader in virtual care, announced executives Jason Gorevic and Mala Murthy will present at the William Blair 40th Annual Growth Stock Conference on June 9, 2020, at 1:00 p.m. EDT. The event will feature a live audio webcast and replay accessible through their investor relations website. Teladoc Health focuses on high-quality, cost-effective healthcare solutions, recognized as the top telehealth provider in the J.D. Power 2019 U.S. Telehealth Satisfaction Study. With over 2,400 employees, it operates in 175 countries, improving healthcare access and outcomes globally.

Teladoc Health (NYSE: TDOC) announced a pricing increase for its offering of Convertible Senior Notes to $850 million, up from the previously stated $800 million. The offering, set to close on May 19, 2020, includes an option for initial purchasers to buy an additional $150 million. The estimated net proceeds are about $829 million, intended for exchanging existing debt, working capital, and general corporate purposes. The Notes will bear a 1.25% annual interest, maturing in 2027, and are convertible under certain conditions. The offering is private and not registered under the Securities Act.

Teladoc Health announced its intention to offer $800 million in Convertible Senior Notes due 2027, with an option for an additional $120 million. Proceeds will be used to exchange existing 2022 Convertible Notes for cash and shares, and also for general corporate purposes, including debt repayment and potential acquisitions. The unsecured notes will pay interest semiannually, with various conversion rights structured into the agreement. The offering will comply with Rule 144A of the Securities Act and is aimed at qualified institutional buyers.